M-2: PHI Pharmacist: TB Treatment

Target Audience

• Pharmacist(PHI/TU)

• Ph-Ch6: General concepts in TB Treatment

  • Goals of treatment
  • Strategies for TB Treatment
  • Pharmacological Basis of treatment
  • Treatment Phases
  • Fixed Dose Combinations [FDC]s
  • Advantages of FDCs
  • FDCs used in NTEP
  • TB Drug Regimen
  • Follow-up of TB patient
  • Long Term Post-treatment follow up of TB patients
  • TB Treatment Outcome
  • Adverse Drug Reactions [ADRs]
  • Types of ADR of TB Treatment
  • Management of Adverse Drug Reactions [ADRs] of TB Treatment
  • TB Treatment Card
  • NTEP TB ID Card
  • Transfer of TB Patient Ownership
  • Management of EPTB
  • Management of Patients with Treatment Interruptions
  • Prevention of Drug Resistance
  • Treatment Regimen for NTM

• Ph-Ch7: DS-TB Treatment and care

  • Categorization of DSTB Treatment Regimen
  • Treatment Regimen for DSTB – Adult
  • Treatment Regimen for DSTB - Pediatrics
  • TB Treatment – Steps
  • ADRs to First Line Treatment

• PHI Pharmacist : DR-TB TREATMENT AND CARE

  • Drug-Resistant Tuberculosis [DR-TB]
  • Goals of DR-TB Treatment
  • Screening for DR-TB
  • Types of Drug Resistance Tuberculosis -DRTB
  • DR-TB Treatment Regimens
  • Pre-treatment Evaluation [PTE] of DR-TB Patients​
  • Second Line anti TB drugs
  • Newer Anti-TB Drugs
  • Weight Band-wise Dosages of DR-TB Drugs for Adults
  • Treatment of DR-TB in Children
  • ADRs to Second Line Treatment
  • Reporting of Adverse Events and Serious Adverse Events

• Ph-Ch9: Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen

  • Shorter oral Bedaquiline-containing MDR/RR-TB regimen
  • Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Treatment Extension
  • Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Drug Dose Administration
  • Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Dosage of Drugs for Adults
  • Possible Adverse Events Due to Drugs in Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen

• Ph-Ch10: Longer Oral M/XDR-TB Regimen

  • Longer Oral M/XDR-TB: Regimen and Duration
  • Treatment Extension in Longer Oral M/XDR-TB Regimen
  • Adverse Drug Reactions due to Longer oral M/XDR-TB Regimen
  • Dosages of M/XDR-TB Drugs for Adult in Longer Oral M/XDR-TB Regimen​

• Ph-Ch11: Isoniazid (H) Mono/Poly DR-TB Regimen

  • Regimen, Duration and Dosage for Isoniazid [H] Mono/Poly DR-TB Regimen
  • Adverse Drug Events: H Mono/Poly DR-TB Regimen

• Ph-Ch12: TB Infection treatment and care

  • TB Infection
  • Testing for TB Infection
  • TB Preventive Therapy
  • Target groups for TPT

• Ph-Ch13: TB-Comorbidities and special situations

  • TB Co-morbidities & Special Situations
  • HIV in TB Patients
  • Diabetes among people with TB
  • Malnutrition among people with TB
  • Alcoholism among people with TB
  • Tobacco use among people with TB
  • Silicosis in people with TB
  • Cancer in People with TB
  • TB in Pregnant and Lactating Women
  • COVID-19 in TB patients

• PHI Pharmacist : GENERAL CONCEPTS IN ADHERENCE MANAGEMENT

  • TB Treatment Adherence
  • Importance of Treatment adherence
  • Recording and Monitoring Adherence
  • Digital Adherence Monitoring Technologies
  • Recording manual doses in Ni-kshay
  • Recording missed doses in Ni-kshay
  • Treatment Support Mechanism
  • Treatment supporter [TS] to TB Patient